deaths from glp 1 RGA GLP-1 Study: Weighing the Evidence A landmark study published in

Purpose-built for physicians GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Combination therapy with a GLP-1 receptor agonist and an SGLT2 inhibitor may provide better weight-loss benefits than a single agent for women with polycystic ovary syndrome and obesity, according to study data

Ann N Y Acad Sci 1019:346349 Richman PG, Meister A (1975) Regulation of gamma-glutamyl-cysteine synthetase by nonallosteric feedback inhibition by glutathione

Thats not a decision to make alone

Trapp S, Cork SC

That's why users report gradual fading over 34 weeks post-cycle rather than immediate loss of pigmentation